Russian full-cycle biopharmaceutical company, a leading developer and manufacturer of innovative medicines and vaccines. Included in the TOP-5 of immunobiological pharmaceutical manufacturers in the Russian Federation
An international innovative biopharmaceutical company whose goal is to expand the capabilities of modern science to create drugs that change the lives of patients for the better.
A company with a rich history in the development of innovative products. There are three main areas: pharmaceutical, ophthalmological.
One of the leaders in the global pharmaceutical industry. The company provides high-quality solutions daily to 200 million people in need of treatment in 100 countries around the world.
One of the leading Russian pharmaceutical companies producing effective, affordable and high-quality medicines for the therapeutic groups most demanded by Russian patients.
Velpharm LLC is a Russian full-cycle pharmaceutical manufacturer that creates modern, effective, safe and affordable medicines.
The company is engaged in the production of medical products, marketing of finished pharmaceuticals, active substances and intermediates, as well as research activities in the field of pharmaceuticals.
A vertically integrated pharmaceutical company, the main activity of which is the research, development and production of drugs for various therapeutic groups.
The company carries out activities for the production, storage and sale of medicines.
The company produces original medicines based on natural chemical compounds (natural metabolites).
PSK Pharma (part of the Rus Biopharm group of companies) is an integrated biopharmaceutical company that produces medicines in the Dubna SEZ (special economic zone) for the treatment of socially significant diseases in various nosologies in a full cycle, including the synthesis of substances. Priority areas of activity: genetically engineered biological drugs, a full line of drugs for the treatment of asthma and COPD, drugs for targeted therapy of autoimmune and orphan diseases. The plant develops and manufactures drugs for the treatment of HIV, tuberculosis, diseases of the gastrointestinal tract and central nervous system.
An international pharmaceutical company with a presence in 148 countries on 5 continents.
An international group of companies, one of the largest manufacturers of generics. For 125 years, it has been helping consumers make a confident choice in favor of high-quality and safe medicines at a fair price.
Joint Stock Company Valenta Pharmaceuticals is a Russian pharmaceutical innovative company founded in 1997 and engaged in the development, production and market launch of high-quality prescription and non-prescription drugs.
The Long Sheng Pharma group of companies has been operating in the pharmaceutical market since 1995. The main office of the company is located in Hong Kong and has represented the interests of the ARPM in the People's Republic of China since 2015, and in Hong Kong since 2016. In the Russian market, the key activity of the company at first was the supply of pharmaceutical substances and excipients for the production of finished dosage forms. Today the company offers its customers complex industrial solutions, while continuing to expand its product portfolio.
An international pharmaceutical company represented by production sites and research and development centers around the world. The company manufactures affordable, high-quality medicines that are trusted by healthcare professionals and patients in more than 150 countries around the world. In Russia, the company is represented by a commercial and production division.